CH666814A5 - Composizione farmaceutica idrosolubile contenente n-acetil-cisteina. - Google Patents

Composizione farmaceutica idrosolubile contenente n-acetil-cisteina. Download PDF

Info

Publication number
CH666814A5
CH666814A5 CH2974/86A CH297486A CH666814A5 CH 666814 A5 CH666814 A5 CH 666814A5 CH 2974/86 A CH2974/86 A CH 2974/86A CH 297486 A CH297486 A CH 297486A CH 666814 A5 CH666814 A5 CH 666814A5
Authority
CH
Switzerland
Prior art keywords
weight
aspartame
nac
sorbitol
acetyl
Prior art date
Application number
CH2974/86A
Other languages
English (en)
Italian (it)
Inventor
Annibale Gazzaniga
Valter Gianesello
Federico Stroppolo
Original Assignee
Inpharzam Int Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inpharzam Int Sa filed Critical Inpharzam Int Sa
Priority to CH2974/86A priority Critical patent/CH666814A5/it
Priority to DE19873723734 priority patent/DE3723734A1/de
Priority to FR878710367A priority patent/FR2601875B1/fr
Priority to NL8701744A priority patent/NL194154C/nl
Priority to BE8700817A priority patent/BE1000168A3/fr
Priority to IT21410/87A priority patent/IT1222103B/it
Priority to SE8702941A priority patent/SE500493C2/sv
Priority to GB8717581A priority patent/GB2192789B/en
Publication of CH666814A5 publication Critical patent/CH666814A5/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CH2974/86A 1986-07-24 1986-07-24 Composizione farmaceutica idrosolubile contenente n-acetil-cisteina. CH666814A5 (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
CH2974/86A CH666814A5 (it) 1986-07-24 1986-07-24 Composizione farmaceutica idrosolubile contenente n-acetil-cisteina.
DE19873723734 DE3723734A1 (de) 1986-07-24 1987-07-17 Pharmazeutische, n-acetylcystein enthaltende, wasserloesliche zusammensetzung
FR878710367A FR2601875B1 (fr) 1986-07-24 1987-07-22 Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et du sorbitol
NL8701744A NL194154C (nl) 1986-07-24 1987-07-23 Farmaceutisch wateroplosbaar preparaat dat N-acetylcysteine en aspartame bevat.
BE8700817A BE1000168A3 (fr) 1986-07-24 1987-07-23 Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et du sorbitol.
IT21410/87A IT1222103B (it) 1986-07-24 1987-07-23 Composizione farmaceutica idrosolubile contenente n acetilcisteina
SE8702941A SE500493C2 (sv) 1986-07-24 1987-07-23 Farmaceutisk, vattenlöslig komposition, innehållande N-acetyl-cystein, aspartam och sorbitol
GB8717581A GB2192789B (en) 1986-07-24 1987-07-24 N-acetyl cysteine granular compositions.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH2974/86A CH666814A5 (it) 1986-07-24 1986-07-24 Composizione farmaceutica idrosolubile contenente n-acetil-cisteina.

Publications (1)

Publication Number Publication Date
CH666814A5 true CH666814A5 (it) 1988-08-31

Family

ID=4245819

Family Applications (1)

Application Number Title Priority Date Filing Date
CH2974/86A CH666814A5 (it) 1986-07-24 1986-07-24 Composizione farmaceutica idrosolubile contenente n-acetil-cisteina.

Country Status (8)

Country Link
BE (1) BE1000168A3 (enrdf_load_stackoverflow)
CH (1) CH666814A5 (enrdf_load_stackoverflow)
DE (1) DE3723734A1 (enrdf_load_stackoverflow)
FR (1) FR2601875B1 (enrdf_load_stackoverflow)
GB (1) GB2192789B (enrdf_load_stackoverflow)
IT (1) IT1222103B (enrdf_load_stackoverflow)
NL (1) NL194154C (enrdf_load_stackoverflow)
SE (1) SE500493C2 (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113559078A (zh) * 2021-07-02 2021-10-29 安徽省先锋制药有限公司 一种乙酰半胱氨酸泡腾片的制备方法

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1217445B (it) * 1988-04-29 1990-03-22 Altergon Sa Composizione farmaceutiche orosolubili contenti acetilcisteina
CH674940A5 (enrdf_load_stackoverflow) * 1988-05-05 1990-08-15 Ibsa Inst Biochimique Sa
DE3909049A1 (de) * 1989-03-18 1990-09-20 Arthur Boskamp Praeparat und dessen verwendung
US5296500A (en) * 1991-08-30 1994-03-22 The Procter & Gamble Company Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy
IT1256616B (it) * 1992-12-02 1995-12-12 Zambon Spa Sciroppo contenente n-acetil-cisteina
GB9226729D0 (en) * 1992-12-22 1993-02-17 Wellcome Found Therapeutic combination
DE4406261C2 (de) * 1993-08-31 1996-07-04 Deutsches Krebsforsch Verwendung von Thiolverbindungen zur Verminderung der Körperfettmenge
DE4329857C2 (de) * 1993-09-03 1995-08-24 Deutsches Krebsforsch Verbindung zur Stärkung des Immunsystems und von Immunreaktionen
BE1007926A3 (fr) * 1994-01-31 1995-11-21 Zambon Int Pharma Composition pharmaceutique contenant de la n-acetyl-cysteine.
US5451405A (en) * 1994-04-25 1995-09-19 Chesebrough-Pond's Usa Co. Skin treatment composition
WO2000018392A1 (en) * 1998-09-25 2000-04-06 Glycox Corporation Limited Fructosamine oxidase: antagonists and inhibitors
EP1115842A4 (en) 1998-09-25 2002-08-21 Glycox Corp Ltd Fructosamine oxidase assay: methods and materials
EP1293251A1 (en) * 2001-09-14 2003-03-19 Holland Sweetener Company V.o.F. Process for the production of alpha-L-aspartyl-l-phenylalanine methyl ester powder
EP2500018B1 (en) 2002-03-08 2017-07-19 PhilERA New Zealand Limited Preventing and/or Treating Cardiovascular Disease and/or Associated Heart Failure
MXPA05002883A (es) 2002-08-20 2005-10-05 Protemix Corp Ltd Formas de dosis y terapias relacionadas.
CA2577634C (en) 2004-07-19 2015-07-07 Protemix Corporation Limited Synthesis of triethylenetetramines
GR1007236B (el) * 2009-12-07 2011-04-08 Uni-Pharma Κλεων Τσετης Φαρμακευτικα Εργαστηρια Αβεε Με Δ.Τ. Uni-Pharma Abee, Νεα φαρμακευτικη συνθεση κοκκιων ν - ακετυλοκυστεϊνης και μεθοδος παραγωγης αυτων
IT1399492B1 (it) * 2010-04-13 2013-04-19 Alpex Pharma Sa Composizioni farmaceutiche effervescenti contenenti n-acetilcisteina.
CN103142505B (zh) * 2013-03-29 2015-03-11 山东罗欣药业集团股份有限公司 一种乙酰半胱氨酸组合物颗粒剂及其制备方法
ES2877679T3 (es) 2017-12-31 2021-11-17 Abdi Ibrahim Ilac Sanayi Ve Ticaret A S Composición farmacéutica que comprende acetilcitisteína sin metilparabeno ni propilparabeno

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617638A1 (de) * 1967-05-24 1971-05-13 Miles Lab Tablettenbindemittel
CH646843A5 (en) * 1982-02-17 1984-12-28 Xyrofin Ag Sugar substitute, method for its production, and its use
DE3317530A1 (de) * 1983-05-13 1984-11-15 Dietrich Dr.med. Sta. Eulalia Ibiza Reichert Antischnarchmittel
AU574360B2 (en) * 1983-05-13 1988-07-07 Reichert, D. Antisnoring agent
DE3317558A1 (de) * 1983-05-13 1984-11-15 Dietrich Dr.med. Sta. Eulalia Ibiza Reichert Orales antischnarchmittel
IT1170268B (it) * 1983-12-21 1987-06-03 Zambon Spa Uso dell'acetilcisteina per ridurre l'incremento della prolieferazione delle cellule basali dell'epitelio respiratoriotracheo-bronchiale indotto dal fumo di tabacco nei mammiferi
DE3514995A1 (de) * 1985-04-25 1986-10-30 Protopharma Ltd., 7831 Malterdingen Verwendung von sulfydrylarzneimitteln zur bekaempfung von schaedigungen der magenschleimhaut

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113559078A (zh) * 2021-07-02 2021-10-29 安徽省先锋制药有限公司 一种乙酰半胱氨酸泡腾片的制备方法

Also Published As

Publication number Publication date
FR2601875A1 (fr) 1988-01-29
GB8717581D0 (en) 1987-09-03
NL8701744A (nl) 1988-02-16
SE8702941D0 (sv) 1987-07-23
GB2192789A (en) 1988-01-27
NL194154C (nl) 2001-08-03
SE8702941L (sv) 1988-01-25
IT1222103B (it) 1990-08-31
NL194154B (nl) 2001-04-02
FR2601875B1 (fr) 1992-02-21
DE3723734C2 (enrdf_load_stackoverflow) 1992-05-21
SE500493C2 (sv) 1994-07-04
DE3723734A1 (de) 1988-02-04
IT8721410A0 (it) 1987-07-23
GB2192789B (en) 1990-01-31
BE1000168A3 (fr) 1988-07-05

Similar Documents

Publication Publication Date Title
CH666814A5 (it) Composizione farmaceutica idrosolubile contenente n-acetil-cisteina.
CH667590A5 (it) Composizione farmaceutica effervescente idrosolubile contenente n-acetil-cisteina. .
Blaschek Natural products as lead compounds for sodium glucose cotransporter (SGLT) inhibitors
US5244670A (en) Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress
US5629013A (en) Chewable calcium carbonate antacid tablet compositions
US5409905A (en) Cure for commond cold
AU627194B2 (en) Pharmaceutical compositions
US4971785A (en) Non-alcoholic delivery system for orally ingestible active ingredients
CZ48199A3 (cs) Způsob inhibování nežádoucí chuti v ústně užívaných prostředcích
DK503687D0 (da) Farmaceutisk praeparat af ibuprofen
DK1207756T3 (da) Anvendelse af spinosad eller en formulering, der omfatter spinosad
ATE73656T1 (de) Entzuendungshemmendes ibuprofen enthaltendes arzneimittel, das in waessriger loesung keinen bitteren geschmack, keine reizung des kehlkopfes und keine intestinale toxizitaet aufweist.
WO2007046890A1 (en) Lozenge for treatment of dry mouth and related conditions
AU665349B2 (en) Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress
JPS62503033A (ja) 固形のむしば予防用口内組成物
WO2009011498A1 (en) Pelargonium sidoides syrup
WO2019060273A1 (en) MOUTHBAT PELLETS FOR AQUEOUS SOLUTION
CA2683701A1 (en) Use of isoosmotic seawater-based ionic solutions for manufacturing medical devices for the prevention of complications of the common cold or of the flu syndrome
IE894050L (en) Compound with gastric acid inhibitory effect and process for¹its preparation
EP0713389A1 (en) Hydrolyzed gelatin as a flavor enhancer in a chewable tablet
US7182964B2 (en) Dissolving thin film xanthone supplement
CH674940A5 (enrdf_load_stackoverflow)
EP1017363B1 (en) Taste masking for unpalatable formulations
CA1136990A (en) Anti-hemorrhagic and anti-inflammatory oral rinse
US20080152677A1 (en) Oral hygiene formulations in the form of capsules

Legal Events

Date Code Title Description
PUE Assignment

Owner name: INPHARZAM INTERNATIONAL S.A. TRANSFER- INPHARZAM S

PFA Name/firm changed

Owner name: ZAMBON SWITZERLAND LTD.

Free format text: INPHARZAM SA#VIA INDUSTRIA#6814 CADEMPINO (CH) -TRANSFER TO- ZAMBON SWITZERLAND LTD.#VIA INDUSTRIA 13#6814 CADEMPINO (CH)

PL Patent ceased